These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10128227)

  • 21. Antitrust exemption: are health providers crying wolf?
    Barnett AA
    J Am Health Policy; 1993; 3(3):38-41. PubMed ID: 10125734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital joint ventures: charting a safe course through a sea of antitrust regulations.
    Joseph JM
    Am J Law Med; 1988; 13(4):621-42. PubMed ID: 3064588
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspectives. Antitrust enforcement: reshaping the health system.
    Kent C
    Faulkner Grays Med Health; 1994 Dec; 48(48):suppl 1-4. PubMed ID: 10138740
    [No Abstract]   [Full Text] [Related]  

  • 24. Preserving antitrust.
    O'Neil-White A; Wilber K
    HMO; 1995; 36(3):15-7. PubMed ID: 10166472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revival of the fittest. PHOs have dropped in number, but many are still going strong despite antitrust scrutiny--and there's even renewed interest.
    Taylor M
    Mod Healthc; 2006 Jun; 36(26):24-6. PubMed ID: 16841648
    [No Abstract]   [Full Text] [Related]  

  • 26. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
    Ewing KP; Koslov TI
    Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
    [No Abstract]   [Full Text] [Related]  

  • 27. Really special treatment. AHA seeks update on federal antitrust statements.
    Taylor M
    Mod Healthc; 2004 Jun; 34(25):8-9. PubMed ID: 15239524
    [No Abstract]   [Full Text] [Related]  

  • 28. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
    Marx D; Busey RC
    J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
    [No Abstract]   [Full Text] [Related]  

  • 29. PPOs facing potential antitrust worries.
    Tarnoff S
    Bus Insur; 1985 Jul; 19(29):16, 20. PubMed ID: 10271746
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitrust enforcement guidelines for providers in the wake of health care reform.
    Zoric S
    J Health Hosp Law; 1993 Dec; 26(12):359-64, 358. PubMed ID: 10138597
    [No Abstract]   [Full Text] [Related]  

  • 31. Planning PPOs to minimize antitrust risk.
    Clanton DA
    Hospitals; 1985 Mar; 59(5):96, 98. PubMed ID: 3972373
    [No Abstract]   [Full Text] [Related]  

  • 32. The new antitrust "safe-harbors".
    Craft JA
    Integr Healthc Rep; 1993 Nov; ():11-3. PubMed ID: 10131005
    [No Abstract]   [Full Text] [Related]  

  • 33. Perspectives. PPOs face antitrust problems.
    Wash Rep Med Health; 1984 Nov; 38(44):suppl 4p. PubMed ID: 10268861
    [No Abstract]   [Full Text] [Related]  

  • 34. An assessment of the anticompetitive effects of preferred provider organizations.
    Greaney TL; Sindelar JL
    Inquiry; 1987; 24(4):384-91. PubMed ID: 2961699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are PPOs a competitive force or antitrust risk?
    Enders RJ
    Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint antitrust enforcement policy: a first step, but questions remain.
    Kopit WG
    Physician Exec; 1994 Jan; 20(1):41-2. PubMed ID: 10132127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dept. of Justice and FTC open the door for greater collaboration.
    Health Care Strateg Manage; 1993 Nov; 11(11):18-9. PubMed ID: 10129687
    [No Abstract]   [Full Text] [Related]  

  • 38. Responding to an antitrust investigation. When the FTC calls, be sure to get an experienced lawyer, cooperate fully and don't be afraid to settle.
    Taylor M
    Mod Healthc; 2004 Nov; 34(45):S3. PubMed ID: 15560636
    [No Abstract]   [Full Text] [Related]  

  • 39. Federal agencies issue new antitrust guidelines.
    Bentley LD
    Radiol Manage; 1995; 17(3):18, 21-3. PubMed ID: 10144825
    [No Abstract]   [Full Text] [Related]  

  • 40. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
    Wright R
    J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.